BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27242226)

  • 1. Expression profile of Rab5, Rab7, tryptophan aspartate-containing coat protein, leprae lipoarabinomannan, and phenolic glycolipid-1 on the failure of the phagolysosome process in macrophages of leprosy patients as a viability marker of Mycobacterium leprae.
    Prakoeswa CR; Wahyuni R; Iswahyudi ; Adriaty D; Yusuf I; Sutjipto ; Agusni I; Izumi S
    Int J Mycobacteriol; 2016 Jun; 5(2):155-63. PubMed ID: 27242226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.
    Verhagen C; Faber W; Klatser P; Buffing A; Naafs B; Das P
    Am J Pathol; 1999 Jun; 154(6):1793-804. PubMed ID: 10362804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
    Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.
    Spencer JS; Kim HJ; Wheat WH; Chatterjee D; Balagon MV; Cellona RV; Tan EV; Gelber R; Saunderson P; Duthie MS; Reece ST; Burman W; Belknap R; Mac Kenzie WR; Geluk A; Oskam L; Dockrell HM; Brennan PJ;
    Clin Vaccine Immunol; 2011 Feb; 18(2):260-7. PubMed ID: 21177913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of zoonotic leprosy in ParĂ¡, Brazilian Amazon, and risks associated with human contact or consumption of armadillos.
    da Silva MB; Portela JM; Li W; Jackson M; Gonzalez-Juarrero M; Hidalgo AS; Belisle JT; Bouth RC; Gobbo AR; Barreto JG; Minervino AHH; Cole ST; Avanzi C; Busso P; Frade MAC; Geluk A; Salgado CG; Spencer JS
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006532. PubMed ID: 29953440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular localization of Mycobacterium leprae-specific phenolic glycolipid (PGL-I) antigen in human leprosy lesions and in M. leprae isolated from armadillo liver.
    Boddingius J; Dijkman H
    J Gen Microbiol; 1990 Oct; 136(10):2001-12. PubMed ID: 2269873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy.
    Spencer JS; Brennan PJ
    Lepr Rev; 2011 Dec; 82(4):344-57. PubMed ID: 22439275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
    Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of peptide mimotopes of phenolic glycolipid-I of Mycobacterium leprae.
    Youn JH; Myung HJ; Liav A; Chatterjee D; Brennan PJ; Choi IH; Cho SN; Shin JS
    FEMS Immunol Med Microbiol; 2004 May; 41(1):51-7. PubMed ID: 15094167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
    Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Macrophage Response to Mycobacterium leprae Phenolic Glycolipid Initiates Nerve Damage in Leprosy.
    Madigan CA; Cambier CJ; Kelly-Scumpia KM; Scumpia PO; Cheng TY; Zailaa J; Bloom BR; Moody DB; Smale ST; Sagasti A; Modlin RL; Ramakrishnan L
    Cell; 2017 Aug; 170(5):973-985.e10. PubMed ID: 28841420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serologic study of naturally acquired leprosy in chimpanzees.
    Gormus BJ; Xu KY; Alford PL; Lee DR; Hubbard GB; Eichberg JW; Meyers WM
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):450-7. PubMed ID: 1890369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type.
    Prasad HK; Mishra RS; Nath I
    J Exp Med; 1987 Jan; 165(1):239-44. PubMed ID: 3540178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epidemiological study of leprosy infection by serology and polymerase chain reaction.
    van Beers SM; Izumi S; Madjid B; Maeda Y; Day R; Klatser PR
    Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):1-9. PubMed ID: 8189074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ locations of Mycobacterium leprae-specific antigens. Immunoelectronoptical studies.
    Boddingius J; Dijkman H
    Acta Leprol; 1989; 7 Suppl 1():107-12. PubMed ID: 2503963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Lipoarabinomannan-Specific Salivary IgA as Prognostic Marker for Leprosy Reactions in Patients and Cellular Immunity in Contacts.
    Nahas AA; Lima MIS; Goulart IMB; Goulart LR
    Front Immunol; 2018; 9():1205. PubMed ID: 29904387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibodies to defined carbohydrate antigens during the course of treated leprosy.
    Gelber RH; Li F; Cho SN; Byrd S; Rajagopalan K; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):744-51. PubMed ID: 2681457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes.
    Schlesinger LS; Horwitz MA
    Infect Immun; 1994 Jan; 62(1):280-9. PubMed ID: 8262640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.